Can I stop taking Ofatumumab?

Ofatumumab (Ofatumumab) is a drug used to treat certain types of leukemia and lymphoma. You should consult your doctor before discontinuing medication, as discontinuation may affect disease progression and treatment effectiveness. Doctors usually decide whether medication can be discontinued based on the patient's specific circumstances and needs. Ofatumumabis a monoclonal antibody that affects the activity of the body's immune system. Monoclonal antibodies can only target and destroy certain cells in the body. This may help protect healthy cells from damage.

Patients can be treated with ofatumumab if they have "active" relapsing multiple sclerosis (relapses and/or new lesions on MRI scans). Ofatumumab is also used to treat chronic lymphocytic leukemia (CLL). In some patients, ofatumumab is given with another drug called chlorambucil. Ofatumumab is sometimes given after other drugs have been tried that have failed. According to the prescription information, patients who experience allergic reactions to ofatumumab should permanently discontinue treatment. It is also contraindicated in patients with activeHBV infection. If patients experience discomfort after use, they should inform their doctors in time and adjust the dosage under the guidance of their doctors.

The original drug of ofatumumab has been launched in China and has also been included in medical insurance. Only patients who meet the indications can be reimbursed. The price is around tens of thousands of yuan, and domestic purchase channels are relatively difficult. The European version of ofatumumab original drug specifications20mg/0.4mL each sold overseas may cost around RMB 16,000 (the price may fluctuate due to the exchange rate). It is expensive and there are currently no generics of ofatumumab. For more drug information and specific prices, please consult a medical consultant.